Keywords: guilford, pharma, sales, decline, losses, creep, up

Guilford Pharma sales decline, losses creep up

Article | 24 February 2003

Print This

Guilford Pharmaceuticals has reported financial results for 2002,with anet loss of $60.0 million, or $2.01 per share, compared to a net loss ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in